The Auxiliary Board is a non-profit organization of Chicago’s young professionals who are dedicated to raising funds for Northwestern Memorial Hospital. Since becoming affiliated with the hospital in 1987, The Auxiliary Board has committed more than $2,000,000 to enhance treatment for Northwestern Memorial’s patients and their families through a host of patient care initiatives.
Northwestern Memorial ranks 11th in the nation in the U.S. News & World Report 2015-16 Honor Roll of America’s Best Hospitals. The hospital is also recognized in 13 of 16 clinical specialties rated by U.S. News and rated No. 1 in Illinois and Chicago in the 2015-16 state and metro rankings.
The Auxiliary Board has pledged its support to a novel research study of type 1 diabetes, led by Jing Jin, MD, PhD in the Division of Nephrology/Hypertension at Northwestern Memorial Hospital and Northwestern University Feinberg School of Medicine.
Often diagnosed in children and young adults, patients afflicted with type 1 diabetes (T1D) need lifelong treatment with insulin and are prone to debilitating and life-threatening complications, including heart disease, stroke and kidney malfunction. T1D is classified as an autoimmune disorder, which occurs when the immune system fails to recognize certain cells of the body as “self” and goes on the attack.
Aiming to improve the understanding of autoimmunity in T1D, Dr. Jin’s team discovered in diabetic mouse models that insulin does sometimes undergo a chemical mutation that causes it to be attacked. His team’s hypothesis is that, when present, attacking antibodies may serve as diagnostic markers and therapeutic targets for humans with T1D. The marker (test) developed in Dr. Jin’s study will be the first of its kind to aid in T1D diagnosis and risk assessment.
The Auxiliary Board of Northwestern Memorial
Hospital for 2016-2017:
|Executive Committee||Board Members|
Joan Vor Broker